Mustang Bio to Participate in the Evercore ISI 2nd Annual HealthCONx Conference

Dec 02, 2019

Fortress Biotech to Participate in December 2019 Investor Conferences

Dec 02, 2019

Fortress Biotech Announces Pricing of Series A Preferred Stock Offering

Nov 25, 2019

Checkpoint Therapeutics Announces Pricing of Public Offering of Common Stock

Nov 20, 2019

Checkpoint Therapeutics Announces Proposed Public Offering of Common Stock

Nov 19, 2019

Fortress Biotech Ranked in Top 10 of Deloitte’s 2019 Technology Fast 500™

Nov 14, 2019

Mustang Bio Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

Nov 12, 2019

Fortress Biotech Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

Nov 12, 2019

Checkpoint Therapeutics Announces Presentation of Anti-PD-L1 Cosibelimab Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 08, 2019

Checkpoint Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

Nov 07, 2019